Status:

UNKNOWN

Comparison of the Effect of Two Interventions on Liver Frailty Index in Pre-frail and Frail Cirrhotic Patients Enlisted for Liver Transplantation

Lead Sponsor:

Pontificia Universidad Catolica de Chile

Conditions:

Cirrhosis, Liver

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

The goal of this prospective, double blind randomized clinical trial is to compare the effectiveness of two interventions in improve frailty (measured by Liver Frailty Index) and quality of life (meas...

Detailed Description

Comparison of the effect of two interventions on Liver Frailty Index in pre-frail and frail cirrhotic patients enlisted for liver transplantation. Frailty is a concept derived from geriatrics that tr...

Eligibility Criteria

Inclusion

  • Presence of cirrhosis.
  • Over 50 years old.
  • Liver Frailty Index of 3.2 points or more.
  • Ability to follow instructions.
  • Ability to consent to study entry.

Exclusion

  • Grade 3 or 4 hepatic encephalopathy.
  • Untreated HIV infection.
  • Previous liver transplant.
  • Inability to walk.
  • Extrahepatic diseases that limit mobility (e.g., neurological or musculoskeletal).
  • Advanced cardiac, renal or pulmonary disease.
  • Expectation of being transplanted during the study period.
  • Hepatocarcinoma (HCC) exceeding the Milan criteria.

Key Trial Info

Start Date :

February 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2023

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06149026

Start Date

February 1 2023

End Date

December 1 2023

Last Update

November 28 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pontificia Universidad Catolica de Chile

Santiago, Santiago Metropolitan, Chile